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2. SCOPE 
 
The scope of this thesis has been organized in three objectives: 
 
The first objective was to find a method to measure the size of the surface area 
of hydrophilic matrices during their swelling. The surface areas of the different 
shapes were explored: that of a cylindrical matrix and that of the Dome Matrix. 
The Dome Matrix is a cylindrical tablet with two curved bases, one convex and 
the other concave. Since the axial section of the matrix appears as a dome it 
was called Dome Matrix. 
 
The second objective was to study the drug release from hydrophilic matrices 
with different geometries but the same formulation and mass. The different 
geometries would lead to different surface area:volume ratios and therefore the 
drug release would proceed with different release rates and different 
mechanisms of release. 
 
In the third objective a new method of matrix assembly was developed. The 
assembly was done by the use of ultrasound and the effects that ultrasound 
could have on drug release from a hydrophilic matrix was studied.
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3. ABBREVIATIONS 
 
BPP  Buflomedil Pyridoxalphosphate 
CAPr         Cellulose Acetate Propionate 
CR  Controlled Release 
EC   Ethylcellulose 
F.U.XI  Farmacopea Ufficiale (Italian) 11th edition 
GIT   Gastrointestinal Tract 
GR  Gastric Retention 
HPMC  Hydroxypropyl methylcellulose 
MMC  Migrating Myoeletric Cycles 
Tg  Glass Transition Temperature 
UV  Ultraviolet 
US  Ultrasound
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4. INTRODUCTION  
 
4.1 THE SWELLABLE MATRIX SYSTEMS            
 
4.1.1 Swelling-controlled release systems 
 
Swelling-controlled systems, also known as hydrogel matrices, polymeric 
matrices, hydrocolloid matrices or hydrophilic matrix, (1,2,3,4) can be utilized to 
manipulate the release of a drug in order to give a controlled time or site of 
release. The different types of swelling-controlled systems include free-
swellable matrices, where the matrix can swell unhindered, swelling-restricted 
matrices, where the matrix surface is modified to alter the swelling of the 
preparation; and finally, the swelling-controlled reservoir systems, where the 
formulation is coated with swellable polymers that control the diffusion of the 
drug from the inner reservoir (5). The advantages of such controlled release 
systems include among others reliable and pH-independent drug release as 
well as better patient compliance, drug targeting to specific anatomical areas 
and protection of drugs from degradation by enzymes or hydrolysis. 
 
4.1.2 Swelling of hydrophilic polymers 
 
It’s the swellable polymer’s viscoelastic properties, rising from the internal 
crosslinks that create a polymer network, which control the release of the drug 
from the preparation. When a swellable matrix is immersed in water, a steep 
water concentration gradient is formed at the interface between the water and 
the polymer matrix. The water first interacts with the hydrophilic groups of the 
polymer, and as these water molecules are quite firmly bound to the polymer 
they are not able to dissolve the drug incorporated in the matrix. As the water is 
further imbibed into the matrix, there are created water-filled spaces inside the 
polymer network that hydrate and dissolve the drug particles. The water acts as 
a plasticizer and lowers the glass transition temperature, Tg, until it reaches the 
actual temperature of the system. The polymer chains then relax and the 
polymer swells (6). If the Tg is above the temperature of the system, the 
polymer chains are in the glassy state and they are too rigid for the drug to be 
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released from the formulation; in the case of HPMC, as it’s glass transition 
temperature is lowered from 184°C in the dry state to less than 37°C when 
immersed in water, the polymer transforms from the glassy state to the rubbery 
state and the polymer chains become more flexible. The swelling causes great 
changes in the matrix with regard to the concentrations of drug, polymer and 
water, the structural organization of the polymer and the mobility of the polymer 
chains (7).  The factors that decide the nature of the drug release from a 
hydrophilic matrix are as follows: 
 
• The polymer content 
• The drug:polymer ratio 
• The solubility of the drug 
• The viscosity of the polymer 
• The particle size of the drug 
• The particle size of the polymer 
• The particle size of any excipients 
• The solubility of the excipients 
• The structure and hydrophilicity of the polymer (8) 
 
4.1.3 Relevant fronts 
 
The interface between the outermost edge of the matrix and the water is called 
the ”erosion front”, since this is where the polymer eventually reaches a level of 
hydration that allows it to disentangle and dissolve, and hence, to erode (9). 
Depending on the characteristics of the polymer, the erosion front will move 
outwards from the core of the matrix if the swelling rate is faster than the rate of 
dissolution of the polymer; and the front will move inwards if the dissolution rate 
exceeds the swelling rate. The swelling- and dissolution properties of the 
polymer are important in determining the matrix’ dimensions and the diffusion 
pathways that the drug may take to leave the system (7). As the water further 
penetrates the polymer matrix, the front where the polymer swells is known as 
”swelling front”. This front always moves inwards towards the core. The swollen 
polymer is termed ”rubbery phase”, and the dry polymer or matrix is termed 
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”glassy phase” (10). If the matrix contains a drug of high solubility and high 
diffusion rate, it is most likely that there will only be these two fronts present. 
However, one may observe a third front if the drug has a low solubility or a slow 
dissolution rate. This front is termed ”diffusion front” and can be found between 
the swelling front and erosion front (11,12), see Figure 1. The diffusion front in 
the rubbery phase of the matrix represents the boundary where the drug 
becomes dissolved. In the same manner as the swelling front the diffusion front 
also moves inwards towards the centre of the matrix. The diffusion front is only 
present if the drug dissolves after the polymer has swelled. Otherwise, the front 
moves in a parallel with the swelling front. Since the polymer swells, the drug 
diffusivity increases as a consequence of the increased water content. When 
the water concentration exceeds the solubility of the drug, complete dissolution 
occurs. The drug can then diffuse out of the matrix (7). As the swelling of the 
matrix advances inwards towards the centre, the diffusional pathway of the drug 
increases, and so the release rate of the drug will gradually diminish. 
 
  
 
 
 
 
 
  
 
 
Figure 1: The different fronts shown as a cross-section of a spherical 
matrix. 
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4.1.4 Mechanisms of drug release 
 
After the polymer has swelled, the dissolved drug can be released from the 
matrix by diffusional mechanisms, termed Fickian, or other mechanisms, such 
as erosion or convective release. The release of the drug is controlled by the 
interaction between the solvent, the polymer and the drug, and the kinetics 
depend on the development of drug gradient in the gel. Therefore the thickness 
of the gel, the drug loading and solubility are the major factors that determine 
the drug release kinetics (10). For example, a large matrix will have a different 
drug release rate than a small matrix because the diffusional distance will be 
quite diverse. A high drug loading under perfect sink conditions will give a 
steeper concentration gradient in the rubbery phase, and the solubility of the 
drug will affect the dissolution time; in fact, a poorly soluble drug might not be 
released by diffusion at all, but by mechanisms such as polymer erosion and 
convective transport. For a polymer that is non-swellable drug release is almost 
solely dependent on diffusion. In this case there is almost no lag time for the 
equilibrium state after the matrix has been solvated. Time-independent, non-
Fickian or case II transport of the drug can be observed in a two-dimensional 
film of hydrophilic polymer when polymer dissolution is equal to the polymer 
swelling. More commonly, in hydrophilic matrices one sees a transport 
mechanism intermediate between Fickian and non-Fickian, namely anomalous 
transport (5).  Polymer relaxation and erosion of the swollen polymer contribute 
to non-Fickian drug release. Other ways of manipulating the drug release 
pattern from a hydrophilic matrix include restriction of the swelling of a 
hydrophilic matrix with an impermeable film, or to create a drug concentration 
gradient within the matrix. If the concentration of drug is gradually increased 
from the outermost border to the centre of the drug delivery device, this will 
compensate for the longer path of diffusion (13).  
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4.1.5 The significance of matrix shape for drug release mechanisms 
 
The shape of the swellable matrix tablets and it’s impact on the drug release 
mechanisms have already been examined by amongst others Ritger and 
Peppas (14), Siepmann, Kranz, Peppas and Bodmeier (15) and Sandaker (16). 
Ritger and Peppas described the change of the diffusional exponent n in 
relation to contribution of diffusional or non-Fickian release as the geometry of 
the releasing device changed. Sandaker treated the release and the 
mechanisms of release of the dome shaped matrices in the flow-through 
dissolution apparatus.  It has earlier been found that if the drug releasing 
surface area remains constant, while the swelling front and the erosion front is 
moving in a parallel manner, the drug release will be constant, or in other words 
it will follow zero-order kinetics. By coating one base and the lateral side of a 
cylindrical matrix with an impermeable film (swelling restricted matrix), the area 
available for drug release and swelling would be constant. However, this cannot 
be achieved with HPMC except for very low polymer concentrations, because 
the solubility of HPMC is too low. Although the use of HPMC in this way did not 
produce zero-order drug release, it changed the kinetics of drug release (5). In 
the thesis of Sandaker (16) the restriction of swelling in dome matrices was 
studied. The dome shaped matrix showed different drug release compared to a 
cylindrical matrix having the same composition and mass. The thesis also 
showed by coating the base surface or the base and lateral surfaces with an 
impermeable polymer film that the drug release from surfaces with nearly the 
same area but with different geometry have different drug release patterns, and 
also quite varying drug release mechanisms. For example was the fractional 
drug release from the concave surface of a dome shaped matrix less than that 
from the convex surface. The concave surface had less contribution of 
diffusional drug release than the convex surface (16). Hence, the shape and the 
surface area of the swellable matrix generally decided the drug release rate and 
mechanisms. 
 
Two or more dome shaped matrices can be assembled in various 
configurations. Dome matrices containing different concentrations of a drug or  
different drugs can be combined after desired patterns. Such an assembly can 
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give patients who need to take more than one drug advantages and enhance 
the compliance of the patient and the convenience of health workers. This 
creates new possibilities for tailoring the drug treatment. It might also solve 
certain production problems that may be connected with production, such as 
compression force, and polymer coating of drugs or tablets. In this thesis the 
assembly of swellable matrices and the influence of assembly on the drug 
release will be studied more closely. 
 
 
4.2 THE POLYMERS 
 
The polymers used in the experiments for this thesis were ethylcellulose and 
hydroxypropyl methylcellulose, two ether derivates of cellulose. Cellulose is a 
natural unbranched polysaccharide composed of glucopyranose units, 
connected by 1,4-β links, and is the major constituent of plant material (17). 
 
4.2.1 Ethylcellulose, EC 
 
Ethylcellulose (EC) is a semi-synthetic cellulose ether, partly O-ethylated. The 
percentage of ethylated groups must according to Ph.Eur.(18) be between 44.0 
and 51.0 percent. The ethylcellulose is insoluble in water, but soluble in some 
organic solvents. It does not swell in water. Common uses are as filling agent 
and thickening agent. 
 
4.2.2 Hydroxypropyl Methylcellulose, HPMC 
 
 
Figure 2: The chemical structure of HMPC. 
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HPMC is also a semi-synthetic cellulose ether with varying degrees of methoxy- 
and 2-hydroxypropoxy-substitution. As one can see from Figure 2, there are no 
ionisable groups and hence the polymer is not sensitive to changes in solvent 
pH. The proportions of the substitutions determines the qualities of the polymer, 
for example the swelling properties, solubility, etc. In the UK the grade of the 
polymer is distinguished by giving the polymer a number that indicates the 
viscosity of a 2% w/w solution at 20°C, in the United States the different grades 
are described by assigning a number where the two first digits indicate the 
percentile of methoxy groups and the third and fourth digits describe the 
percentile of hydroxypropoxy groups. The USP defines four different grades of 
HPMC, based on the percentage of substitution, namely 1828, 2208, 2906 and 
2910 (17). The HPMCs are soluble in cold water, but insoluble in hot water or 
dehydrated alcohol (18). When introduced in water or another hydrophilic 
solvent, the HPMCs swell, creating a network of entangled chains held together 
by secondary forces. This process is reversible, and on drying a solution of 
HPMC a film is formed. Except from the use as a slow release agent, drug 
carrier, coating agent, etc in drug formulations, HPMC is also used as an 
emulsifier, gelling agent, stabilizer, film former and suspending agent in foods 
(19,20). In the research for this thesis HPMC with the trade name Methocel 
was used. The Methocel K100M HPMC corresponds with the USP quality 2208, 
with 19,0-24,0% methoxy substitution and 4,0-12,0% hydroxypropoxy 
substitution. The Methocel used was of the K100M type, which has longer 
chains and is of the least erodible quality (16). 
 
4.3 ASSEMBLY WITH ULTRASOUND 
 
4.3.1 Ultrasound background 
 
Ultrasound is energy in the form of sound waves with a frequency of 1 to 5 
megahertz. It is inaudible to the human ear, and so far no significant risks of 
health damage have been observed with the use of ultrasound for medical 
examinations. In addition to the diagnostic application ultrasound has previously 
been used for industrial purposes such as welding and molding plastic materials 
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for purposes such as car manufacturing and product packaging. Ultrasonics has 
also been used for cleaning objects such as surgical instruments (21). It has 
also been shown that ultrasound can enhance transdermal penetration of drugs, 
also drugs with a higher molecular weight, such as proteins (22,23). Rodriguez 
et al. (24) applied ultrasound to compact tablets consisting of Eudragit and 
theophylline. Using ultrasound as a method of welding the modules together as 
mentioned previously in part 4.1.5 is very efficient (the modules remained 
assembled throughout the entire duration of the dissolution test) and it does not 
involve the use of organic solvents nor is it time consuming. The assembly of 
release modules with different composition given together can ease the 
problems of polypharmacy and create personalized dosage systems with 
dosaging and release kinetics adapted for the individual patient. 
 
4.3.2 Mechanism of ultrasound soldering 
 
The soldering of the single units in one piece depends on the thermoplasticity of 
the contents in the release units. The energy of the ultrasound waves is 
transferred to the release unit or module and there is a consequent rise in 
temperature. As the temperature exceeds the Tg of the contents, in this case 
the HPMC, the polymer chains become more flexible. While the temperature 
still is higher than the Tg of the polymer the chains of the different modules 
entangle and as the temperature drops, the polymer becomes rigid once more. 
The energy applied has created a new conformation and entanglement of the 
chains of the separate modules, and this has led to their attachment (see Figure 
3). All this happens during a very short amount of time. In the work performed 
for this thesis, ultrasound was applied for 0.55 seconds. 
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Figure 3: The behaviour of polymers during ultrasound soldering, the red 
lines representing the polymers of the lower module and the blue lines 
representing the polymers of the upper module. 
 
The energy of the ultrasound waves that were applied had to be changed 
accordingly to how many modules we wanted to assemble. For the assemblage 
of two or three modules the energy required was around 15J. For four to six 
matrices to be united, a higher energy was needed, about 25-30J. 
 
4.4 MECHANISMS OF RELEASE AND THE MATHEMATICAL MODELS 
 
4.4.1 Models for description of release mechanisms 
 
Many different mathematical models have been proposed to describe the drug 
release mechanisms from hydrophilic matrices. Using an appropriate equation 
would make it possible to calculate and predict these processes. However, at 
the present the most common equations have limitations to their use, as it is 
necessary to make certain assumptions about the models. One example is the 
model proposed by Cohen and Erneux (25,26), which assumes that there is 
only swelling in one dimension. Consequently, this model cannot successfully 
be applied to a three-dimensional system such as the dome-shaped matrices 
studied in this paper.  
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4.4.2 Fick’s Law 
 
Fick’s Law describes the purely diffusional release rate of a drug. In the case of 
swellable matrices the drug diffusion rate is proportional to surface area and the 
drug concentration gradient between the diffusion front and the erosion front. 
Assuming quasi steady-state conditions, Equation 1 could be applied to 
swellable matrices: 
 
dm
dt
= Dk
h
 
  
 
  ⋅ A ⋅ ∆C        Equation 1 
 
Here, dm/dt represents the diffusion rate, D the drug’s diffusion coefficient in the 
swollen polymer, k the partition coefficient of the drug, h the drug’s distance of 
diffusion inside the swollen matrix, i.e. the distance between the diffusion front 
and the erosion front, A is the surface area of the matrix and ∆C is the 
concentration gradient of the drug, that is C0-Ci where C0 is the drug 
concentration at the diffusion front and Ci the concentration at the erosion front.  
 
4.4.3 The Ritger-Peppas equation 
 
In this paper we have applied the Ritger-Peppas equation (Equation 2), a semi-
empirical model for the analysis of release data.  
 
M t
M∞
= ktn                                                Equation 2  
 
In this equation Mt is the amount of drug released at time t, M∞ is the amount of 
solute released after infinite time. Mt/ M∞ is the fractional solute release. t is the 
release time and k is the release constant, which is dependent of the system, 
i.e. polymer, solvent, drug loading, excipients, etc. n is the diffusional exponent 
characteristic of the release mechanism of the system. 
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4.4.4 Advantages and disadvantages of the Ritger-Peppas equation 
 
Equation 2 was used to study the mechanism of release, because this equation 
has favorable aspects as regards limitations and assumptions. One assumption 
that must be made is that there are perfect sink conditions during the swelling, 
and that diffusion is concentration independent. The Ritger-Peppas equation 
can only be applied to the first 60% of fractional drug release (14). It is also 
important to consider that there is a delay before the outermost edges of the 
matrix have been hydrated (27). In our experiments we have assumed that 
steady state for the HPMC-matrices occurs after 10 minutes, and this is 
considered in our calculations. Thus, we insert the lag time l in Equation 2: 
 
M t
M∞
= k(t − l)n        Equation 3 
 
4.4.5 The diffusional constant n 
 
The release of drug from the matrices depends mainly on diffusion through the 
matrix, swelling of the polymer and erosion of the swollen polymer (9). 
Diffusional release shows first order kinetics or Fickian kinetics. In the case of 
Fickian release the release kinetics are therefore proportional to the square root 
of time, or t1/2. With a pure diffusional drug release, n in Equation 2 is equal to 
0.50 if the swellable device is a thin film. This is however not the case with 
matrices of other shapes. Previously, it was assumed that only the value of k 
would change with varying geometries of the matrix systems, but Ritger and 
Peppas showed that not only the k changes with different shapes of the 
formulation, but also the value of n. As can be seen from Table 1, in the case of 
pure diffusional release, n may have a value in the range between 0.43 in a 
spherical system and 0.50 in a thin film (14).  
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Table 1: Diffusional exponent and mechanism of diffusional release from 
various non-swellable controlled release systems (14). 
    Diffusional exponent  
Thin Film Cylindrical sample Spherical sample
Drug release 
 mechanism 
0.50 0.45 0.43 Fickian diffusion 
0.50<n<1.00 0.45<n<1.00 0.43<n<1.00 Anomalous  
(non-Fickian) 
1.0 1.0 1.0 Zero-order release 
 
When the only mechanism of release is non-Fickian, the release rate is 
independent of time. This means that the value of n is 1, and that the drug 
release is zero order. This fact does not change with any change in the 
geometry of the system. Normally, the value of n lies somewhere in between 
the limits, as the release mechanism rarely is purely diffusional or purely non-
Fickian. However, Ritger and Peppas stated that the aspect ratio of the matrix 
influences the value of n (14), so that it is not always correct to assume that the 
value should be 0.5 (see Table 1). The aspect ratio is given by the equation 
2a l , where 2a represents the diameter of the matrix when the radius is a, and l 
is the thickness of the matrix.  
 
Another equation regarding the contributions of Fickian and non-Fickian drug 
release has been proposed, by the Peppas-Sahlin’s equation, which is valid for 
the first 60% of drug released. 
 
M t
M∞
= k1t m + k2t 2m        Equation 4 
 
In this equation k1 is the kinetic constant for Fickian contribution of drug release 
and k2 is the kinetic constant for Case II contribution, and m is the diffusional 
exponent. m is equal to n in Equation 2 when the case II mechanism is 
negligible. As in the example of a thin polymer film, m would be 0.50 for a pure 
diffusional release mechanism and in this situation 2m would equal 1. Because 
of the uncertainty concerning the contribution and importance of polymer 
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relaxation in the drug release from the Dome Matrix, this equation will not be 
used to estimate m in this thesis. 
 
4.4.6 The swelling area number (the Parma number) 
 
Another way of describing the mechanisms of drug release is to apply the 
swelling area number, Sa (Equation 5). 
 
Sa = 1D ⋅
dA
dt
        Equation 5 
 
In the equation of the swelling area number, D represents the drug’s diffusion 
coefficient. It must be stressed that D in this case is the diffusion coefficient in a 
gel and not that in water. DA/dt represents the change in area within a certain 
amount of time. The swelling area number is dimensionless and the different 
values describe the contribution of diverse drug releasing mechanisms: 
 
Sa >> 1 indicates diffusional drug release 
Sa = 1 indicates anomalous drug release 
Sa << 1 indicates case II drug release 
 
Another important feature of this equation is that it states that drug release is 
proportional to the releasing area, a part that Ritger and Peppas’ equation fails 
to describe.  
 
4.5 GASTRIC RETENTION 
 
Because the modules can be assembled in such a way that they create a 
floating device, the subject of floating devices for enhanced gastric retention will 
also be treated in this thesis. There have been developed several different 
gastroretentive devices based on various techniques; among others the 
effervescent floating systems, where excipients such as sodium bicarbonate 
and citric or tartaric acid develop a gas upon contact with the acidic contents of 
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the lumen (28). Others are microballoons, hydrodynamically balanced systems, 
expanding systems, etc. 
 
4.5.1 Advantages and possibilities of gastroretentive systems 
 
The scope of creating a gastroretentive (GR) device is to improve the 
bioavailability and consequently the therapeutic efficacy of the drug. Firstly, this 
is achieved by prolonged gastric retention time (GRT), a favorable effect since 
the gastrointestinal passage time is very variable, from a few minutes to more 
than 12 hours into the stomach. This provides more time for the drug to be 
released, so that sustained release devices do not run the risk of going through 
the passage of the gastrointestinal tract (GIT) too quickly with insufficient 
amounts of drug being released (29). Secondly, gastroretention may also 
provide site-specific drug delivery, for example localized treatment of ulcers with 
prostaglandins. This localized treatment may also decrease systemic side 
effects and increase the dosage intervals (30). Also, prolonged GRT can 
provide site-specific drug delivery for drugs that have a greater absorption from 
the upper GIT than the lower parts of the intestine and colon, an example being 
the drug furosemide (29). However, it has not been shown that prolonged GRT 
gives any greater absorption of drugs that already have good absorption 
qualities along the full length of the GI (31). GR formulations may also be used 
as formulations for drugs that are acid-soluble or that are unstable and/or have 
poor solubility in the intestinal environment (32,33). 
 
4.5.2 Limitations of GR systems 
 
Nevertheless, there are also limitations to the floating gastroretentive 
formulations.  The influence of the presence of food in the stomach is decisive 
for the amount of time that the formulation remains in the lumen. The passage 
though the stomach in the fasted state is variable, from almost immediate 
gastric emptying up to 3 hours retention due to the migrating myoelectric cycles 
(MMC). This cycle involves four phases with different contractional activity. The 
third phase is also called “the housekeeper wave”, and is the phase with the 
most intense contractions, completely emptying the gastric content and 
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sweeping it down the intestine. As a result of this, if a GR device is taken 
immediately before such a “housekeeper wave” there will be no gastric retention 
and the scope of the formulation will be lost. However, in the fasted state the 
MMC is interrupted and the gastric emptying is delayed. Consequently, in the 
fed state the gastric retention time is more predictable and prolonged, even 
though there may be great inter- and intrasubject variations (34). Another 
disadvantage of GR devices is that drugs with high first-pass metabolism might 
have their bioavailability reduced by increased gastric retention (31). In addition, 
the buoyancy of the device is dependent of than a sufficient volume of liquid is 
present in the lumen. 
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5. EXPERIMENTAL  
 
5.1 EQUIPMENT AND MATERIALS 
 
5.1.1 Equipment 
 
1. Reciprocating tableting machine: Emil Korsch Maschinenfabrik Berlin 
9341-72, Germany. 
2. ”Mitutoyo”, an advanced caliper. 
3. USP 26 Apparatus 2; ERWEKA DT 6 R, Germany. 
4. Peristaltic pump: ESAPUMP, Advanced Products srl. 
5. UV/VIS spectrophotometer: Jasco V-530 
6. Ultrasound apparatus: Branson WPS21 
7. Turbulator: WAB Turbula, Type T2A nr.720213 
 
5.1.2 Materials 
 
1. Hydroxypropyl methylcellulose (Premium Methocel K100M), Colorcon, 
Orpington, UK (Particle size < 125µm). 
2. Buflomedil pyridoxalphosphate (Pirxane), Lisapharma S.p.A., Erba, CO, 
Italy (Particle size < 125µm, solubility in water at 37°C: 65g/100ml). 
3. Magnesium stearate 24762 Eigenmann & Veronelli S.P.A. 
4. Acetone, RPE Carlo Erba Reagenti, Milan, Italy 
5. Ethylcellulose, provided by Lisapharma S.p.A., Erba, CO, Italy 
6. Eudragit L30, a 30% w/w dispersion of Methacrylic Acid and Ethyl 
Acrylate Copolymer (1:1). 
7. Castor oil ( F.U.XI.) 
8. Cellulose acetopropionate (CAPr) (Eastman Chemical Company, 
Kingsport, TN, USA) 
9. Titanium dioxide: A.C.E.F. (F.U.XI). 
10. Triethylcitrate (Fluka-Chemie GmbH). 
11.  Methylene blue: A.C.E.F. (F.U.XI). 
12.  2-propanol, RPE
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6. METHODS 
 
6.1 THE MATRICES 
 
6.1.1 Matrix preparation 
 
The formulation of the matrices studied in this thesis was intended to be as 
simple as possible, avoiding the use of any excipients, to facilitate the study of 
drug release without having to consider the effects of other substances than the 
polymer and the drug. Therefore, it was chosen to use a binary powder mixture 
for direct compression. The mass of the matrices was kept constant, with only 
the geometry varying. 
 
When preparing the powder mix for the matrices, the buflomedil 
pyridoxalphosphate (BPP) powder was previously kneaded in a mortar, and the 
powder was then sieved with a sieve with a mesh size of ≤125µm. This powder 
was then mixed with polymer, either hydroxypropyl methylcellulose (HPMC) or 
ethylcellulose (EC), in a Turbula mixer. The relative ratio of drug and polymer 
was 60 parts drug to 40 parts polymer. The powder mix was ready for 
compaction after approximately 15 minutes of mixing. The matrices were made 
by direct compression in a tableting machine operated by hand. Since there 
were no other excipients, it was necessary to lubricate the punches frequently 
using a suspension of magnesium stearate in acetone to prevent the matrices 
from sticking to the punches. The different polymers and the different shapes of 
the punches demanded different frequencies of lubrication and cleaning. There 
were made HPMC matrices of four different geometries: cylindrical dome 
shaped matrices, cylindrical flat based matrices, cylindrical matrices with one 
base flat and the other convex and cylindrical matrices with one base flat and 
the other concave. The diameter of the punches used was 7.4mm. Of the 
BPP:EC mixture there were only made two kinds of modules, the dome shaped 
module and the cylindrical flat based module. The compression force for each 
type of module, having different volume/surface ratios was between 25kN and 
35kN. The tablets produced with the higher force appeared to have a brighter 
yellow color than those produced with a lower compression force. According to 
Methods 
 
 25
Bettini et. al. (35) the compression force has no influence on the kinetics of 
matrix swelling, and subsequently it isn’t necessary to consider the differences 
between the pressures used when producing the matrices when performing the 
dissolution tests.  After the compression of the matrices, each matrix was 
weighed to assure that the weight was within the desired interval, 120mg ± 
5mg, and the thickness of the lateral border was measured to guarantee that all 
the tablets of the same geometry were not significantly different in size.  
 
6.1.2 BPP content of the matrices 
 
For each of the different powder mixes used for the production of the tablets, 
the content of BPP in the different matrices was determined. This was 
performed by randomly taking six matrices and kneading them in a mortar. 
From the powder thus produced, there were taken three samples of 
approximately 120mg, the average weight of the matrices. Each of these three 
samples were then dispatched in 500ml of distilled deionized water, which were 
let to dissolve with agitation at 37°C for at least 2 hours. After the all the powder 
had dissolved, 3 samples of 5ml each were taken from the solution and 
individually diluted until 50ml with distilled deionized water. These dilutions were 
then subjected to measurement of UV absorbance at a wavelength of 282nm 
with the path length of the cells being 1cm. The absorbance coefficient of Beer’s 
law for BPP had previously been determined to be 11.93L*mol-1*cm-1, and thus 
using the measured absorbance with Beer’s law gives the resultant amount of 
BPP in the matrices. The stability of BPP in water is high enough that 
degradation doesn’t need to be taken in account when calculating the 
percentage of BPP in the formulation. 
 
6.1.3 The geometry of the matrices 
 
The modules used in the drug release experiments had as previously 
mentioned in total 4 different geometries. They were made either with the 
punches with curved surfaces at the tips, with punches with circular, flat 
surfaces or a combination of these two sets of punches. The punches have a 
circular shape in the lateral section and have the dimensions shown in Figure 4. 
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       Upper punch       
       (Concave face of matrix)                                       
                                                                                                                                                         
                                                                            a = 7.46 mm                                                        
                                                                    b = 6.06 mm 
       c = 1.35 mm 
       d = 0.70 mm 
       e = 0.85 mm 
 
        
       Lower punch 
       (Convex face of matrix) 
        
a = 7.47 mm 
       b = 6.16mm 
           c = 1.80 mm 
            d = 0.645 mm 
 
Figure 4: Shape and approximate dimensions of the punches with curved 
tips. 
 
The flat punches have a diameter of 7.4 mm and have a flat shape. The four 
different geometries of the matrices are as follows: 
 
1. The dome module, made with the upper and lower punch having curved 
tips. The matrix has an axial section that resembles a dome, hence the 
name Dome Matrix. The shape is a cylindrical matrix with one base 
concave and the other base convex. 
2. The cylindrical module. This is made with the cylindrical punches having 
flat tips. 
3. The flat/concave module, made with the upper punch having a convex 
shape, and the lower punch having the flat shape. The shape is a 
cylindrical matrix with one side concave. The axial section resembles a 
cup shape, with one base concave and the other base flat.  
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4. The flat/convex module, made with the upper punch with the flat tip and 
the lower punch with a concave shape. The matrix has a shape with a 
convex base and a flat base. 
 
The shapes are shown below in Figures 5 and 6. 
 
 
 
 
 
 
                The dome module           The cylindrical module 
 
 
 
   
 
 
           The flat/concave module          The flat/convex module 
 
Figure 5: The shapes of the different matrices. The dotted lines represent 
the edges on the inside or on the backside of the matrices. 
   
       
 
 
 
Figure 6a: The dome module.                 Figure 6b: The cylindrical module. 
 
       
 
 
 
Figure 6c: The flat/concave module.        Figure 6d: The flat/convex module. 
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As can be seen from Figures 5 and 6a, the dome module has the possibility of 
different ways of assembly. The dome module may be assembled with the 
convex face of one matrix inserted into the concave face of another matrix, such 
creating a monolithic structure, which in this thesis is called the stacked 
configuration. This last type of assembly was applied to 2, 3, 4, 5 or 6 matrices 
at a time, see Figure 7. In this way it was possible to create structures that 
would require an excessively large compression force if made with a standard 
tableting machine.  
 
 
 
 
 
 
Figure 7: The different “stacked” configurations with 2,3,4,5 and 6 
modules assembled. 
 
Also, modules with different drug and excipient compositions could be 
assembled into these structures giving rise to dosage forms with a 
heterogeneous distribution of drug(s) and/or polymer(s), which would be difficult 
using normal direct compression as method of production.  
 
The second conformation created by dome module assembly that was tested 
was the configuration as seen in Figures 8 and 9, where there is a void inside 
the final structure by assembling two dome shaped matrices with their concave 
bases facing each other. This void will create a density of the dosage form that 
is lower than that of water, and hence floats. This can for example be utilized to 
create a gastroretentive dosage form of the polymer matrix, or as a press-on 
coating for other formulations. 
 
 
 
 
 
 
Figure 8: The void conformation. 
 
Methods 
 
 29
 
 
 
 
 
 
 
Figure 9: The “void” configuration, seen from two diverse angles. 
 
6.1.4 The dimensions of the matrices 
 
The dimensions of the different surfaces of the matrices were measured using a 
precision caliper. The different modules used in the experiments were 
measured, and the average measurements of the different surfaces were then 
used to calculate the surface area of the matrices. The weights of the matrices 
were kept the same for all the different geometries of the matrices. For example 
the flat/concave and the flat/convex matrices have a quite significant difference 
in surface area. We decided that the matrix mass should be the same for all the 
matrices to facilitate the comparison between different release curves. The 
compression force was kept between 25kN and 35kN to obtain satisfactory 
crushing strengths for all the different modules. 
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The different dimensions have the characterizations shown in Figures 10, 11, 
12 and 13, and these will be referred to in Table 2 and 3:  
 
 
 
 
 
 
Figure 10: The designations of the different parts of the dome matrix. The figure 
with the dotted lines represents the inside of the dome module, for practical 
reasons. 
 
 
 
 
 
Figure 11: The designations of the different parts of the cylindrical modules. 
 
 
 
 
 
 
Figure 12: The designations of the different parts of the flat/concave modules. 
 
 
 
 
 
 
Figure 13: The designations of the different parts of the flat/convex modules. 
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Table 2: The average dimensions and areas of the manufactured BPP- 
HPMC modules. 
SURFACE FORMULA DOME CYLINDIC
FLAT/ 
CONCAVE 
FLAT/ 
CONVEX 
Convex A = π r2 + h2( ) 
h1=2.1 
r1=3.2 
A=45.2
- - 
h1=1.9 
r=3.2 
A=42.9 
Shelf 
border 
A = π R2 − r2( ) 
R=3.7 
r1=3.2 
A=12.8
- - 
R=3.8 
r=3.2 
A=13.3 
Lateral A = H ∗ 2πR 
H=2.4 
R=3.7 
A=56.6
h=2.2 
r=3.7 
A=51.8 
H=3.3 
R=3.8 
A=77.7 
h2=1.4 
R=3.8 
A=33.4 
Concave A = π R2 + h2( ) 
h2=2.2 
r2=3.0 
A=43.6
- 
h=2.3 
r2=3.0 
A=44.1 
- 
Base 
border 
A = π R2 − r2( ) 
R=3.7 
r2=3.0 
A=16.1
- 
R=3.8 
r2=3.0 
A=16.8 
- 
Flat face A = πR2  - r=3.7 
A=43.3 
R=3.8 
A=44.4 
R=3.8 
A=44.4 
Sum mm2 A∑  174.3 138.5 182.9 134.0 
Sum cm2  1.74 1.39 1.83 1.34 
Where not indicated, the numbers are given in the dimension of millimeters. 
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Table 3: The average dimensions and areas of the manufactured BPP-
EC modules. 
SURFACE FORMULA DOME CYLINDIC 
Convex A = π r2 + h2( ) 
h1=1.9 
r1=3.2 
A=43.1 
- 
Shelf border A = π R2 − r2( ) 
R=3.8 
r1=3.2 
A=12.7 
- 
Lateral A = H ∗ 2πR 
H=2.4 
R=3.8 
A=57.5 
h=2.3 
r=3.7 
A=54.0 
Concave A = π R2 + h2( ) 
h2=2.2 
r2=3.0 
A=43.0 
- 
Base border A = π R2 − r2( ) 
R=3.8 
r2=3.0 
A=16.4 
- 
Flat face A = πR2  - r=3.7 
A=43.8 
Sum mm2 A∑  172.8 141.6 
Sum cm2  1.73 1.42 
Where not indicated, the numbers are given in the dimension of millimeters. 
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6.1.5 The coating of the matrices 
 
In the previous work done by Sandaker (16), the drug release from partially 
coated matrices was studied. To achieve this, a solution that would create an 
impermeable film upon drying was produced by mixing 7.5 g of CAPr, 1.05 g of 
castor oil (1.1 ml), 1.48 g of triethylcitrate (1.3 ml), 0.01 g of methylene blue, 4.5 
g 2 -propanol (6.2 ml) and 15.7 g acetone (20 ml). A sufficient volume of this 
liquid was then applied to the base surfaces or the base and lateral surfaces 
and left to dry at room temperature. Methylene blue was added to ease the 
visual control of the position of and complete coverage by the film (Figure 14). 
 
 
 
 
 
Figure 14: Example of partially coated matrices. 
 
In this thesis we wished to examine further the swelling and release rates of the 
matrices, and so the coating was repeated as described above. 
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6.2 THE ASSEMBLY OF THE DOME MODULES 
 
6.2.1 Assembly with ultrasound 
 
A new method for assembly of two or more matrices with the application of 
ultrasound (US) waves was developed using a Branson ultrasound machine. 
This method consisted of stacking the matrices in the desired conformation and 
then placing them in a cylindrical die made especially for every conformation 
under a custom-made ultrasonic probe made from titanium. The sonotrode 
emitted ultrasonic waves at desired frequency, time and energy. The matrices 
would then attach to each other. The parameters used for assembly of the 
matrices were an energy of 15-30J, duration of application of US 0.55 seconds.  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 15: The Branson ultrasound   Figure 16: Detail of the ultrasound 
machine.                                             machine, the sonotrode and the die for the                          
     matrices. 
                                                                       
Assembly was only performed with the BPP-HPMC dome modules. The surface 
area of the configurations produced by the ultrasound assembly is shown 
beneath in Table 4, and their surface area:volume ratios in Table 5. 
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Table 4: The surface area of the assembled HPMC modules. 
CONFIGURATION/ 
SURFACE 
2 
modules 
stacked 
3 
modules 
stacked 
4 
modules 
stacked
5 
modules 
stacked 
6 
modules 
stacked 
Void
Concave base 59.7 59.7 59.7 59.7 59.7 - 
Convex base 58.0 58.0 58.0 58.0 58.0 
58.0 
x2
Lateral 56.2 56.2 56.2 56.2 56.2 56.2
Sum area (mm2) 230.2 286.5 342.7 398.9 455.2 228.5
Sum area (cm2) 2.30 2.87 3.43 3.99 4.55 2.29
Where not indicated, the numbers are given in the dimension of millimeters, the 
areas are derived from table 2. 
 
Table 5: The volumes and the surface area:volume ratios of the single 
dome and the assembled configurations. 
 
CONFIG-
URATION 
 
1 
single 
dome 
2 
modules 
stacked 
3 
modules 
stacked 
4 
modules 
stacked 
5 
modules 
stacked 
6 
modules 
stacked 
Void 
Volume 
(cm3) 
0.10 0.21 0.31 0.41 0.52 0.62 0.21*
Surface 
area: 
volume 
ratio 
17.40 10.95 9.25 8.37 7.67 7.33 10.90
* This does not include the volume of the void inside the assembled 
configuration. 
The areas are taken from table 4, 
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6.3 THE DRUG RELEASE EXPERIMENTS 
 
The drug release experiments were performed using an USP apparatus II (see 
Figure 17), paddle speed being 75 rotations per minute and the temperature 
37°C. The release medium was distilled, degassed water. The volume of water 
used was either 500ml or 1000ml. Since the solubility of BPP was very good the 
perfect sink conditions were maintained though the whole drug release 
experiments, and thus the experiments were not influenced by the volumes of 
water that were used. During the dissolutions the perfect sink conditions were 
maintained. The wavelength used to measure the absorbance and the amount 
of drug released was 282nm. The cell path length was 1mm. Measurements 
were performed at fixed time intervals, controlled by computer programs. The 
time length of the intervals between every measurement was adjusted after 
which polymer that was used. For the EC modules, the measurements were 
first made every 3 minutes for 51 minutes and then every 15 minutes. For the 
HPMC modules, the measurements were made every 15 minutes for 2 hours, 
and thereafter every hour. All the dissolutions were continued until the increase 
in UV absorbance had stagnated, a sign of completed drug release. 
 
 
 
 
 
 
 
 
Figure 17: The computer, spectrophotometer, pump and paddle apparatus 
used during the dissolution. 
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6.4 MATHEMATICAL TREATMENT OF THE RELEASE DATA 
 
6.4.1 Finding the drug fraction released 
 
After obtaining the values of absorption from the dissolutions, the absorbance of 
the blank, that is the absorbance of the dissolution medium, was subtracted 
from the absorbance measured at different times. The resulting value was then 
applied in Beer’s law (Equation 6) as the absorbance, A.  
 
A = a ⋅ b ⋅ c        Equation 6 
 
In this equation a represents the absorbance coefficient of BPP, previously 
determined experimentally (value 11.93). b is the path length of the cells 
(0.1cm). c is the concentration of drug in the solution under examination. By 
knowing the volume of the dissolution medium in which the matrix has been 
introduced it was possible to find the mass of drug that has been released. This 
was then divided by the total amount of drug originally contained by the matrix 
in order to calculate the fraction released. 
 
Fraction released = m
m∞
= V
m∞
⋅ A
a ⋅ b     Equation 7 
 
6.4.2 Finding n 
 
To find the diffusional constant n, the first 60% of the drug released is plotted 
versus time using a mathematical computer program, Kaleidagraph (Synergy 
Software, Reading, USA). Then, a power equation of the type y = a ⋅ xn was 
fitted to the data. The program calculated the values of the two coefficients of 
the Ritger-Peppas equation (Equation 2). Finally, the computer adjusts the 
coefficients to match the data at an error of not more than 0.05%, and the value 
of n was found. 
 
Methods 
 
 38
6.4.3 Finding the release rate 
 
The experimental release rate was easily found by taking the derivative of the 
curve fitted to fraction released vs. time and then multiplying the resultant 
values with the total amount of drug originally contained by the matrix. 
 
6.5 AREA OF THE MATRICES DURING THE SWELLING PROCESS 
 
As the matrices were introduced into the drug release medium, it was imbibed 
into the matrix. This caused the polymer to swell and the volume of the system 
to increase. HPMC swells faster than it dissolves, and as a consequence of this 
the surface area of the matrices also increased. The swelling and enlargement 
of the matrix developed over time. As the matrices reached a gel-like 
consistency, direct measurements of the magnitudes of the different sides were 
difficult without changing the three-dimensional shape of the matrices.  
 
The partially coated matrices (see section 6.1.5) were attached to a glass plate 
(with the coated base down facing the plate) and introduced into the vessel 
holding the drug release medium. The glass plate enabled the removal of the 
matrix from the vessel during the drug release experiment without deforming the 
geometric shape. The matrix removed from the vessel was then placed next to 
a ruler and a photo was taken with a digital camera. This was repeated with 
regular intervals of time for all the different matrices, that is, until ∼80% of the 
drug was released from the matrices. The matrices were returned in the 
dissolution medium as quickly as possible to interfere as little as possible with 
the normal swelling of the modules. The drug release was recorded during the 
whole dissolution period as a means to ensure that the swelling of the matrices 
was no different than the normal release during dissolution under the same 
circumstances. These release data were however not used for further 
calculations due to the disturbance in the experiment. Then a computer 
program (Image J, USA) was applied, which enabled us to find the real size of 
the objects in the photos. Then the outlines of half of the swollen matrices were 
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traced using the computer program, creating a two-dimensional outline of the 
matrices (see Figure 18).  
 
 
 
 
 
 
 
 
Figure 18: Example of photo taken of a cylindrical matrix after 300 
minutes, with tracing of the outline on the right hand side. 
 
The points that were created during the tracing process are coordinates later 
used to calculate the surface area of the swollen matrices by then applying an 
integral formula, as shown in Equation 8: 
 
Ax = f x( )
a
b∫ 1+ ′ f x( )[ ]2 dx        Equation 8 
 
In this manner an approximate number for the magnitude of the three-
dimensional surface of the swollen matrices could be found. The method was 
validated by taking a photo of a sphere of known size and applying the method 
to calculate the surface of the sphere. The area was calculated with an error of 
9.6%.  
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7. RESULTS  
 
7.1 THE DISSOLUTION EXPERIMENTS 
 
7.1.1 Visual observations 
 
In addition to the UV measurements, there were also made visual observations 
of the matrix behaviour. In general, the BPP-HPMC modules, both single and 
assembled first remained at the bottom of the drug release medium, and after 
120-240 minutes they started to float. This does of course not include the 
floating devices, which remained buoyant during all of the dissolution tests. 
During the dissolution experiments of the flat/concave a hole was seen in the 
base of the tablet. 
 
7.1.2 The single BPP-HPMC matrices 
 
The dissolutions performed with single BPP-HPMC matrices gave the results 
displayed in Figure 19 and showed that there was a slight but varying difference 
between the release patterns of the four different shapes. That is, the dome, the 
flat/concave, the flat/convex and the cylindrical matrices. The slowest release 
pattern is the one of the flat/convex matrices. Due to these matrices’ different 
areas of release (see Table 2 in section 6.1.4) this result makes sense, as a 
larger initial area of release gives a faster release of the drug. However, the 
fraction released does not give any information on the relative contribution of 
the different mechanisms of drug release from the swollen matrix. The Ritger-
Peppas equation was applied to study the effects of matrix geometry on the 
drug release mechanisms.  
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Figure 19: Drug release from 
the single swellable units and 
the respective diffusional 
values of n for the first 60% 
released. 
 
 
 
 
 
 
 
The different shapes produce different paths of drug diffusion. In fact, the 
distances for the drug to diffuse in order for the drug to be released were of 
different length depending on the matrix geometry. For example the diffusion 
path in the flat/concave modules was quite small, since the walls of the matrix 
were quite thin, and drug was in this was released faster. This fact contributes 
to differences in release rates, as seen below in Figure 20. The flat/convex 
matrix has, even though the size of the initial releasing area is close to the one 
of the cylindrical matrix, the lowest release rate of the modules. The difference 
between the release rates was not very great. 
 
 
 
Figure 20: Release rates from the 
single matrices. 
 
 
 
 
 
 
 
Results 
 
 42
0
0.2
0.4
0.6
0.8
1
0 20 40 60 80 100 120 140 160
Drug Release from the Single EC Modules
EC Dome Module n= 0.56 ± 0.03
EC Cylindrical Module n= 0.58  ± 0.03B
PP
 F
ra
ct
io
n 
R
el
ea
se
d
Time (min)
7.1.3 The single BPP-EC matrices 
 
As EC is an inert polymer, there was no swelling present during the release of 
drug from the matrices. Drug release should therefore depend solely on 
diffusion. After about 175 minutes the total amount of drug in the matrices was 
released, as shown in Figure 21. It can also be seen that drug was released 
faster from the dome module. It appears also as if that the release rate from the 
cylindrical module was quite constant between about 40 and140 minutes, as the 
shape of the curve is almost linear. 
 
 
Figure 21: Fraction released from 
BPP-EC matrices. 
 
 
 
 
 
 
 
 
 
 
The release rate from the BPP-EC matrices is shown in Figure 22. The dome 
module had an initially higher release rate than the cylindrical module. After 
about 60 minutes this changed, and it was the cylindrical module that had a 
higher release rate. The release rate between 40 and 140 minutes was less 
constant, as first appearances of Figure 21 might imply, but had a slow 
decrease during all this period of time. 
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Figure 22: The release rates of the 
BPP-EC matrices . 
 
 
 
 
 
 
 
 
 
7.1.4 The stacked configurations 
 
The matrices that were assembled in the stacked configuration showed a 
release pattern as shown in Figure 23. 
 
 
Figure 23: Fraction released 
vs. time for the single dome 
and the stacked configurations 
with the n values for the first 
60% of drug released. 
 
 
 
 
 
 
 
As can be seen, the fractions released from the stacked modules fanned out 
with 2 stacked modules having the higher fractional drug release all times of the 
dissolution, then followed in order of decreasing fractional drug release 3, 4, 5 
and 6 stacked modules. All the stacked modules had a more prolonged release 
than a single dome module. The diffusional values n were not very different 
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from the diffusional constants of the single dome modules. The release rates of 
the stacked configurations are presented in Figure 24. 
 
 
Figure 24: Release rates of 
the stacked configurations. 
 
    
 
 
 
 
 
 
 
It is clear that the release rate of the configuration with 6-stacked modules was 
the highest, followed in decreasing order by 5-, 4-, 3- and 2- stacked modules. 
The kinetics of release are however similar, as the paths of the curves show.  
 
7.1.5 The void configuration 
 
The result from the dissolution of the modules assembled in the void 
configuration is here shown together with the release patterns of a single 
module and the 2-stacked configuration. Only the results of the void matrices 
that stayed completely attached during the whole dissolution test were 
considered, even though the ones that disassembled kept their buoyancy during 
the whole experiment. Figure 25 shows that the drug release was very similar to 
that of the 2-stacked configuration.  
Results 
 
 45
0
0.2
0.4
0.6
0.8
1
0 200 400 600 800 1000
Drug Release from HPMC Modules
Dome Module n= 0.62 ± 0.01
2-Stacked Modules n= 0.61 ± 0.01
Void Configuration n= 0.67 ± 0.02B
PP
 F
ra
ct
io
n 
R
el
ea
se
d
Time (min)
0
0.2
0.4
0.6
0.8
1
0 200 400 600 800 1000
Release Rates from HPMC Modules
Dome Module
2-Stacked Configuration
Void configuration
B
PP
 R
el
ea
se
 R
at
e 
(m
g/
m
in
)
Time (min)
 
Figure 25: Release from dome, 
2-stacked and void Modules and 
their respective n-values for the 
first 60% of drug released. 
 
 
 
 
 
 
 
 
 
Figure 26 shows the release rates from the void configuration compared with 
the release rate from the single dome module and the 2-stacked. It is clear that 
the void configuration had a release rate very close to the 2-stacked matrices. 
 
 
Figure 26: Release rates of 
dome, 2-stacked and void 
configurations. 
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7.2 THE MEASUREMENT OF THE SWOLLEN SURFACES 
 
The photos taken of the swollen matrices gave the sizes of the surface areas 
after the respective times shown in Tables 6 and 7: 
 
 
Table 6: The area of swelling base surfaces vs. time. 
      Surface 
Time 
Convex Concave Flat 
60 minutes 103.9±2.3 mm2 75.1±2.5 mm2 82.0±1.7 mm2 
120 minutes 135.0±1.2 mm2 99.1±3.2 mm2 99.1±2.5 mm2 
180 minutes 170.4±8.3 mm2 103.0±2.0 mm2 121.3±3.7 mm2 
240 minutes 179.8±5.0 mm2 105.7±2.7 mm2 131.1±6.6 mm2 
300 minutes 174.0±3.5 mm2 109.0±0.8 mm2 146.5±2.1 mm2 
360 minutes 196.7±3.3 mm2 115.6±5.6 mm2 175.8±4.6 mm2 
420 minutes 206.6±1.3 mm2 106.5±2.7 mm2 164.5±5.0 mm2 
 
 
 
 
Table 7: The area of swelling base- and lateral surfaces vs. time. 
        Surface 
Time 
Convex and 
lateral 
Concave and 
lateral 
Flat and lateral 
60 minutes 163.8±6.5 mm2 180.2±6.5 mm2 167.7±18.2 mm2 
120 minutes 194.5±8.5 mm2 209.5±8.5 mm2 182.0±3.6 mm2 
180 minutes 232.0±3.5 mm2 207.0±6.2 mm2 197.7±10.0 mm2 
300 minutes 231.7±6.2 mm2 255.6±4.0 mm2 210.5±1.3 mm2 
360 minutes 252.3±7.5 mm2 255.4±6.4 mm2 216.8±7.6 mm2 
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A better way to illustrate the increase in area vs. time is by using graphics (see 
Figure 27 and 28): 
  
 
Figure 27: The increase of the area of   
the swelling of partially coated matrices 
with only one base free for swelling plotted 
against time. 
 
  
 
 
 
 
Figure 28: The increase of the area of the 
swelling of partially coated matrices with 
one base and the lateral surface free for 
swelling plotted against time.  
 
 
 
 
 
 
As can be seen, the surface area of all the matrices increased as the dissolution 
test progressed. For the matrices where one base and the lateral surface that 
were coated with an impermeable film (single base surfaces concave, convex 
and flat free for swelling), the largest surface area was exhibited by the convex 
module. The concave module had the smallest surface area. For the 
measurements performed on matrices having only one surface coated (one 
base and the lateral surface free to swell), the surface area was not so 
differentiated, but the matrices with one flat base and lateral surface showed the 
smallest surface area. However, the pattern of surface increase was not easy to 
describe with a simple equation, as the results show no clear sequential order 
except that of gradual increase; they can at best be described with polynomial 
equations of the second degree. 
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8. SOURCES OF ERROR 
 
8.1 THE MAKING OF THE TABLETS 
 
The measurements of drug release were performed by the use of an UV-
apparatus. Since it was the amount of drug released that was measured in this 
manner, it was important that the stability of BPP was sufficient during the tablet 
production. BPP is a colored substance, and as other colored substances it is 
prone to be sensitive to degradation by light. To avoid this type of degradation, 
the compresses used were never older than six months and were kept 
protected from light except from during the experiments. By treating the 
matrices in this way it is unlikely that this is a source of great error. 
 
The aspect of weighing, sieving and mixing the drug and the polymer in the 
tablets is dependent of the operator, and the risk of human mistakes was 
definitely present. In addition BPP exhibited electrostatic properties, and might 
have complicated the weighing and the mixing of the powders.  
 
8.2 THE DISSOLUTION EXPERIMENTS 
 
The stability of BPP could also cause erroneous measurements during the 
dissolution, as the drug would be exposed to light up to 27 hours. However, 
there was no clear tendency of the measurements made over such a period of 
time to imply that the experiments were affected by this. 
 
The calculation of the surface area of the dry matrices was done with the caliper 
by hand. This means that the measurements were dependent not only on the 
precision of the instrument (precision= 0.01mm), but also on the operator. To 
avoid this the measurements were carried out by two persons. The results 
should therefore not be a major source of error. 
 
Different pressures were probably used during the production of the tablets, as 
there were slight differences in the color of the matrices. This could depend on 
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the operator of the tableting machine, but also on the weight of the tablet in 
production. However, as mentioned earlier, since the tableting force and hence 
the porosity of the matrices are not of importance for drug release rate (35). 
 
The volume of the dissolution medium might have varied some, as the 
temperature made the water evaporate and during the experiments there were 
observed droplets of water hanging under the lids of the vessels. In addition 
there were gaps in the lids where the vapor could diffuse out. Nevertheless, it is 
not probable that the loss of volume would be large enough to contribute to 
significant error. 
 
The spectrophotometer sometimes showed instable measurements, and to 
avoid this to contribute to the errors, a blank sample was always run in parallel 
to the matrix samples. This way it was easier to find if the variances were 
caused by the spectrophotometer or actual fluctuations in the drug release, and 
variances caused by the UV-spectrophotometer could be adjusted. 
Nonetheless, this could be a rather large contribution to errors. 
 
8.3 THE MODULE ASSEMBLY 
 
As the modules were assembled with ultrasound one could observe a small 
particulate cloud that originated from the matrices. However, the assembled 
matrices were weighed after assembly and so the data used in the calculations 
are accurate.  
 
There was not done any measurements or examinations to learn if the US 
treatment caused any changes in the matrices, for example drug breakdown or 
alteration of polymer structure. This may also be a cause of error, but as the 
dissolution results were considered “normal”, it is unlikely that this has great 
contribution to the sum of errors. However, this should have been examined, 
but lack of time limited these investigations. 
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The data from each assembly that was made were not recorded. They could 
have given more information of the process of assembly, but this is not a direct 
error source. 
 
8.4 THE SWOLLEN AREA MEASUREMENTS 
 
The method of measuring the surface of the matrices as they were swelling is 
still at an experimental level, and has many sources of error. There is for the 
moment the need to coat the matrix surfaces, so that the swelling does not 
occur in the manner that it would in a matrix with non-restricted swelling. 
In addition, the matrix had to be attached to a glass plate in order to remove it 
from the dissolution medium. This glass plate plus the adhesive used might 
have changed the diffusion- and swelling pattern. 
 
The matrices had to be removed from their vessels to be photographed, which 
means that the matrices were out of the dissolution medium for some time, and 
this clearly would affect swelling.  
 
As the photos were taken, there was difficulty in placing the matrices in the 
exact same position every time. This would mean that they could be placed in 
various positions relative to the ruler used to set the scale of the photo, and the 
measurements of each photo would thus vary. 
 
For the flat/concave matrices, it was not possible to calculate the surface area, 
because the concave part of the matrix would not appear on the photos as they 
taken from the lateral side showed a section of the matrix. There was no other 
angle that made possible the description of the flat/concave three-dimensional 
shape. This contributes to a large uncertainty of the area measurements made 
of the flat/concave modules. 
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9. DISCUSSION 
 
9.1 THE DISSOLUTION EXPERIMENTS 
 
9.1.1 Discussion of the single BPP-HPMC matrices 
 
The different shapes of the matrices produce different paths of diffusion that 
give rise to differences in release rates. It is not unexpected that the drug 
release patterns of all the different types of matrices are slightly different, 
bearing in mind their diversity in geometry. Considering the initial releasing area 
of the matrices and assuming that the relative differences between the module’s 
areas is sustained during the whole dissolution experiment, Figure 19 clearly 
shows that the modules with the larger releasing area, the flat/concave module, 
has the fastest fractional drug release compared to the others. Also, the hole 
that formed in the base of this module during dissolution contributed to the 
surface area of the module becoming even larger. Then in descending order of 
releasing area and release rate follows the dome module, the cylindrical module 
and at last with the slowest drug release the flat/convex module. The difference 
in initial surface area of the cylindrical and the flat/convex modules is rather 
small in comparison to the other modules, but still the release of drug from the 
flat/convex is significantly different from the cylindrical module. The divergence 
of release pattern may be explained by the longer diffusional distance for the 
drug molecules inside the flat/convex module compared to the cylindrical one. 
Also, the module with the fastest drug release is the one where the drug has a 
short diffusion path inside the matrix.  
 
Hence, the modules with the larger initial area of release have the highest initial 
fractional drug release. The release rate found experimentally seems to indicate 
a shift in the release rates in the direction of higher release rate values in the 
modules that had the smaller initial area of release between 350-400 minutes. 
This is probably because the matrices with the preliminary slower release rates 
at this moment have a higher concentration of drug in the matrix, and so the 
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diffusion gradient ensures that the release rate doesn’t slow down as quickly as 
for the other modules.  
 
The diffusional exponents n of the diverse modules have slightly varying values, 
but they are not significantly different. This shows that the mechanisms of drug 
release are approximately the same for all the different geometries. In other 
words the equilibrium between the diffusional release and non-Fickian release 
is approximately equal between the different types of modules. The value n 
can’t be directly applied since the aspect ratios of the different modules vary 
throughout their structures. Nonetheless, it can be said that there is 
considerable contribution of non-Fickian drug release mechanisms as the 
values were between 0.62 and 0.65. 
 
As for the industrial aspect of producing the modules, the formulation of the 
matrices needs adjustments if there should be an upscaling of the module 
fabrication. So far the matrices have been made one by one using a hand-
driven tableting machine, with the need for lubricating the punches for every two 
or three tablets produced. The powder mixture will at least need the addition of 
glidants and lubricants. A change in formulation will also require new tests of 
the matrices’ properties. 
 
9.1.2 Discussion of the single EC matrices 
 
The drug release from the EC modules shows the same tendency as the 
release from the single HPMC modules, where the module with the larger 
releasing area, the dome module, has a faster release of drug. In this case the 
matrices do not swell and we can assume that the surface area of the matrices 
remains the same throughout the whole dissolution. 
 
Even though the only mechanism of release from the EC modules should be 
diffusion, the value of n has the value 0.56 ± 0.03 for the dome shaped modules 
and 0.58 ± 0.03 for the cylindrical modules. The aspect ratio of the cylindrical 
matrices, found by dividing the diameter with the thickness, is 3.34 and should 
therefore have a value of about 0.45 according to Ritger and Peppas (14). A 
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probable reason for the elevated value of n might be that there was observed a 
disintegration of the tablets during the dissolution tests, in this manner erosion 
of the polymer matrix might contribute to these elevated values. Even though 
only the data of the tablets that didn’t disintegrate in any degree possible to 
observe with the naked eye were used, it is very likely that there was a slight 
disintegration or dissolution of the polymer. This in turn will have affected the 
dissolution of the drug. 
 
9.1.3 Comparison of release from BPP-EC matrices and BPP-HPMC 
matrices 
 
The dissolutions with the BPP-EC matrices were carried out in order to compare 
the drug release from swellable matrices to matrices that contained a non-
swellable polymer. Even though there is another release mechanism for the EC 
modules other than just diffusion, the values were used to show the significant 
difference in n values between a non-swellable and a swellable polymer matrix. 
It is also quite obvious from Figure 29 that the swelling of the HPMC has a great 
influence on the drug release. The time required for release the total amount of 
drug in the HPMC matrix is more than twice as long as for the EC matrix.  
 
 
 
Figure 29: BPP release from 
matrices made from EC and 
HPMC and the respective n-
values for the first 60% of drug 
released. 
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Although in this case it is probable that other mechanisms such as erosion of 
EC might contribute to increase the value of the diffusional constant n, the value 
of n is significantly different (P < 0.05) for the two different polymer matrices, 
this confirms what Ritger and Peppas described (14), that the value of n 
increases with increasing contribution of non-Fickian drug release, a 
phenomenon typical of swellable matrices.  
 
If another non-swellable polymer had been used instead of the EC, where the 
problems of erosion might have been avoided, one might have seen an even 
greater difference between the HPMC and the non-swelling polymer. 
 
9.1.4 Discussion of the stacked modules 
 
It is obvious that when the dome modules are assembled, the ratio of releasing 
area to drug mass of the releasing device will be different than the area:drug 
mass ratio of the single matrices. As a consequence the release of drug is also 
changed. It would obviously not give the same effect to use a certain number of 
single modules instead of one of the corresponding stacked configurations, 
since the release from single modules will not be dependent of the number of 
matrices as long as perfect sink conditions can be sustained. The diffusional 
exponents n of the stacked matrices were not very different from the diffusional 
constants of the single matrices. The shape, or surface area has little influence 
on the mechanism of release from the BPP-HPMC formulation that we have 
used. However, the n of the single modules or modules in the 2-stacked 
configuration was significantly different from the n of the 6-stacked 
configuration. 
 
The differences in the kinetics when the release rate is normalized to the mass 
of drug, that is the derivate of the fraction released vs. time, are of such a small 
dimensions that they are negligible. The release rate is mostly dependent of the 
drug mass as the number of modules in the device increases, because the 
change in ratio between releasing area and drug mass does not decrease too 
much. Only for the 2- and 3- stacked ratios, the difference in release area is 
notable, and this explains the diminishing difference between the matrices of 
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different conformation. As more modules are added the change in releasing 
area vs. drug mass simply declines and would finally give a convergence of the 
fraction released vs. time.  
 
The derivative of the curves of release rate is plotted against time for all the 
different stacked configurations in Figure 30, and since the curves in Figure 30 
completely superposition each other it is clear that the difference in release 
rates from the differently stacked modules is mostly dependent on the drug 
mass in the matrix.  
 
  
 
Figure 30: Derivative of fraction 
released stacked configuration. 
 
 
 
 
 
 
 
 
 
 
The thought of changing the drug release from matrices without changing the 
formulation, but only by assembling them is interesting and there is yet to be 
seen how the release from devices constructed by modules of varying contents 
will be. Different polymers in the different modules might bring about an 
enhancement or delay in drug release, and different concentrations of drug the 
same. Also the presence of another drug might give unforeseen effects on the 
drug release from the matrices. 
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9.1.5 Discussion of the void configuration 
 
The drug release from the void modules is nearly equal to that of the 2-stacked 
configuration. This is not very surprising, as they have approximately the same 
releasing area. The significance of this is that there will be little or no difference 
in the drug release from a floating configuration and a drug delivery device 
made without creating buoyancy when dissolution otherwise is carried out under 
the same conditions. Hence, no particular considerations need to be taken to 
the drug or excipients when manufacturing tablets of the void configuration 
compared to when making oral formulations, as long as the final assembled 
module has a density that is less than that of the dissolution medium. 
 
Another possible way to use the void configuration other than as a floating 
device is to fill the void inside the assembled polymer matrices with a tablet or 
powder that contains the same or a different drug. In this way, it is possible to 
release the drug in the outer part first followed by the release of the drug in the 
inner part. This could in addition be an alternative to spray-coating with HPMC, 
which does not only require the use of organic solvents, but also is time-
consuming. One example of a possible use of the void is as a colonic release 
device, for example as a modification of the Chronotropic system, a device 
created by Sangalli et al., consisting of a drug core, surrounded by a layer of 
hydrophilic polymer applied by spray-coating and then coated with a gastro-
resistant layer (36). By using the void configuration, the application of the drug 
polymer to the drug core would be a lot faster, without the need for solvents and 
it would also be much more facile to control the thickness of the polymer layer. 
 
9.2 THE ULTRASOUND ASSEMBLY 
 
The assembly of the modules by use of ultrasound was simple regarding the 
need of technical insight; this is a great advantage of this method, implying that 
it can easily be used by personnel in for example hospitals or nursing homes.  
However, often during the assembly the modules did not attach very well to 
each other, the height of the probe would have to be adjusted or the energy 
used would also have to be modified. It seemed that tablets that had been 
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made with a slightly higher force of compression adhered better to each other 
than the ones made with a slightly lower pressure. Also sometimes the modules 
would break or attach to the probe. The success rate became quite higher after 
there were made dies that could be assembled onto the ultrasound machine 
and hold the modules in place during the soldering process. The contact 
surface of the probe could also be modified to give a larger contact surface and 
less sharp edges. 
 
As the formulation of the powder mixture used for the making of the tablets was 
made as simple as possible to ease the research of drug release and polymer 
swelling, it seemed that the mixture was not optimal for module assembly. If the 
mixture could be modified to enhance the soldering, one might achieve a 
greater ease of assembly. Also the dome-shaped modules did not have a 
perfect fit into one another and the shape should be adjusted so that the 
surfaces of the modules have the maximum contact surface area possible, as 
this will help adherence. 
 
There has not been performed any studies of the effect of the energy the 
ultrasound waves has on the stability of the drug and polymer or if there are 
created any unwanted interactions between polymer and drug for this thesis. 
This obviously has to be investigated before going any further with research and 
in vivo experiments. 
 
As for upscaling of matrix assembly, there should be no problems of mass-
assembly as long as the one can construct an ultrasound machine made for this 
purpose. The biggest obstacle would probably be the cost of designing and 
constructing this kind of machinery. 
 
9.3 THE SWOLLEN SURFACE AREAS 
 
The problem of measuring the swelling area is evident; if one tries to measure 
the surface area of a matrix without attaching it to a surface, the shape of the 
matrix will be distorted due to the gel consistency that develops during swelling. 
Hence, some part of the matrix is not free for swelling and the process of 
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swelling is altered. This means that any direct measurement would be almost 
impossible to perform. In addition, whenever there was a concave curvature of 
the matrix, the angle necessary for making the photographs did not show the 
actual surface area, since the curvature was hidden inside the matrix. Also, the 
impermeable film probably intervenes with the natural swelling process and thus 
the surface areas measured in this thesis are not in accordance with the areas 
of a normal free-swelling module. 
 
The measurement the surface area of the swelling matrices could be useful for 
applying the swelling area number, in order to understand the contribution of the 
different release mechanisms during drug dissolution. However, this requires 
the knowledge of the diffusional coefficients of the drug in gels. Yet, if these 
parameters are known, then one can also compare the swelling area number to 
the n to see if there is any connection between these two coefficients. 
 
One alternative to measure the swelling area would be to develop an optical 
scan, preferably one that if capable to perform measurements while the matrix 
is still in the dissolution medium. Another alternative is to develop a 
topographical model that could describe the development of shape and surface 
area during the swelling. 
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10. CONCLUSIONS 
 
10.1 RELEASE FROM THE DIFFERENT MODULES 
 
From what has been seen from the experiments with the single modules of 
different geometry, it can be seen that the mechanisms of drug release changes 
when the shapes of the matrices are varied. The most important influence that 
the matrix geometry exerts is the enhanced release rate from the matrices with 
a larger initial surface area but with the same mass  and formulation.  
 
10.2 ULTRASOUND ASSEMBLY 
 
The use of ultrasound seems to be a promising method of module assembly, 
being safe and easily applicable. The equipment and formulation of the tablets 
should be adjusted in such a manner that the assembly will be easier and have 
a higher success rate for each assembly. The ultrasound waves do not change 
the release from matrices, but the assembly leads to changes in the surface 
area: volume fraction that influences the drug release patterns. 
 
10.3 SWOLLEN AREA CALCULATIONS 
 
There are too many sources of error in the method of measurement that we 
have applied, thus the true swelling area of uncoated matrices was not 
calculated in this thesis, as there was no such applicable method. However, the 
measurements made give an idea of how the matrices swell, even though they 
don’t give an exact number. A better approach should be found to assure that 
the area calculated is correct. If the true swelling area is obtained, the swelling 
area number can be applied and used to study the drug release mechanisms.
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